Strs Ohio Sells 141,300 Shares of Sabra Healthcare REIT, Inc. $SBRA
Strs Ohio reduced its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 16.2% in the first quarter, selling 141,300 shares. Following the sale, Strs Ohio now holds 729,700 shares valued at approximately $14.0 million. Sabra Healthcare REIT reported Q1 earnings of $0.16 per share, meeting expectations, with revenue of $211.74 million, surpassing estimates and showing a 20.9% year-over-year increase.
Louisiana State Employees Retirement System Acquires New Holdings in Sabra Healthcare REIT, Inc. $SBRA
The Louisiana State Employees Retirement System has initiated a new position in Sabra Healthcare REIT (NASDAQ:SBRA), purchasing 73,100 shares valued at approximately $1.4 million during the first quarter. Sabra Healthcare REIT reported Q1 earnings matching expectations at $0.16 per share, with revenue of $211.74 million surpassing estimates and showing a 20.9% year-over-year increase. The company also declared a quarterly dividend of $0.30 per share, amounting to an annualized yield of about 6.0%, while analysts currently rate the stock as a "Hold" with a target price of $21.30.
Citi Maintains Sabra Health Care REIT Inc(SBRA.US) With Hold Rating, Maintains Target Price $19
Citi has reiterated its Hold rating on Sabra Health Care REIT Inc (SBRA.US) and maintained its target price at $19. This indicates a neutral stance on the stock's future performance according to the analyst firm.
American Healthcare raised to Buy, Sabra Health cut to Neutral at Citi (SBRA:NASDAQ)
Citi has upgraded American Healthcare REIT (AHR) to Buy from Neutral, citing its recent underperformance as an attractive entry point. Concurrently, Sabra Health Care (SBRA) has been downgraded to Neutral from Buy following this reevaluation. The shift reflects analyst Seth Bergey's new outlook on the relative investment merits of the two companies.
Sabra Health Care REIT (SBRA) Stock Could Be 20.7% Undervalued After Recent Pullback
Sabra Health Care REIT (SBRA) stock has pulled back recently, down 14% over the past month and 11% over the past three months, despite positive multi-year returns. Trading at $18.05, the stock is considered 20.7% undervalued compared to a fair value estimate of $22.77, driven by a supply-demand imbalance in senior housing and anticipated revenue growth and margin expansion. However, this valuation could be challenged if supply increases faster than expected or if operator transitions impact occupancy and cash flow.
Sabra Health Care (SBRA) grants 8,310 stock units to director Ann Kono
Sabra Health Care REIT, Inc. director Ann Kono received an equity award of 8,310 restricted stock units as compensation. These units, granted at no cash cost, will vest in equal monthly installments from July 17, 2026, through June 17, 2027, or the day before the next annual stockholders' meeting. Following this grant, Kono holds a total of 68,186 stock units, including both unvested and vested-but-deferred units.
Sabra Health Care REIT (SBRA) grants 8,310 RSUs to director Cusack
Sabra Health Care REIT (SBRA) director Catherine Cusack was granted 8,310 restricted stock units (RSUs) at no cash cost, increasing her direct holdings to 82,056 shares and stock units. These RSUs will vest in equal monthly installments starting July 17, 2026, and ending by June 17, 2027, or the day before the next annual stockholders' meeting. The grant was made under Sabra's 2009 Performance Incentive Plan.
Lynne Katzmann of Sabra Health Care REIT (SBRA) receives 8,310 RSUs
Lynne S. Katzmann, a director at Sabra Health Care REIT, Inc. (SBRA), was granted 8,310 restricted stock units (RSUs) as part of the company's 2009 Performance Incentive Plan. These RSUs, which represent the right to receive one share of common stock each, were awarded at no cash cost and will vest in equal monthly installments starting July 17, 2026, until June 17, 2027, or the day before the next annual stockholders' meeting. Following this grant, Katzmann holds a total of 86,121 stock units, comprising the new unvested units and previously vested but deferred units.
Sabra Health Care REIT (NASDAQ: SBRA) director granted 8,310 stock units
Sabra Health Care REIT director Craig A. Barbarosh was granted 8,310 restricted stock units as equity compensation under the company's 2009 Performance Incentive Plan. These units, which vest monthly starting July 17, 2026, were received at no cash cost and are not an open-market trade. Following this grant, Barbarosh directly holds 63,326 stock units and indirectly holds 94,916 shares through The Barbarosh Family Trust.
Sabra Health Care REIT, analyst focus on dividend and earnings outlook
Analysts are closely scrutinizing Sabra Health Care REIT (SBRA) focusing on its dividend sustainability, operator health within its skilled nursing portfolio, and capital recycling efforts. The REIT's first-quarter 2026 funds from operations and updated outlook are influencing analyst models. Sabra's valuation is primarily viewed with neutral to positive ratings, with target prices near its current share price, reflecting a balanced risk-reward profile compared to its healthcare REIT peers.
Sabra Health Care REIT (NASDAQ: SBRA) investors approve directors, pay and auditor
Sabra Health Care REIT (NASDAQ: SBRA) stockholders approved all proposals at their annual meeting on June 17, 2026. This included the election of seven directors, the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026, and an advisory approval of the compensation for named executive officers. The voting results demonstrate strong shareholder support for the company's governance and executive pay practices.
Community Healthcare Trust vs. Sabra Health Care REIT: Which Real Estate Stock Is a Better Buy in 2026?
This article compares Community Healthcare Trust (CHCT) and Sabra Health Care REIT (SBRA) as potential investment opportunities in 2026, focusing on their business models, financial performance, risk profiles, and valuations. While CHCT targets smaller outpatient facilities, SBRA focuses on large-scale senior housing and skilled nursing properties, which could benefit from the aging baby boomer population. The author suggests Sabra may be more attractive given current market conditions and long-term demographic trends despite recent share price drops.
2,654,480 Shares in Sabra Healthcare REIT, Inc. $SBRA Acquired by Centersquare Investment Management LLC
Centersquare Investment Management LLC has acquired a new position in Sabra Healthcare REIT, Inc., purchasing 2,654,480 shares valued at approximately $50.3 million. This new stake represents about 1.06% of the company. Other institutional investors have also adjusted their holdings in SBRA, which reported Q1 earnings matching expectations and an annual dividend yield of 6.5%.
SBRA vs. CUBE: Which Stock Is the Better Value Option?
This article compares Sabra Healthcare (SBRA) and CubeSmart (CUBE) to determine which is a better value option for investors. Based on Zacks Rank and valuation metrics like P/E and P/B ratios, SBRA is identified as the superior value choice due to its stronger earnings outlook and more favorable valuation figures.
Sabra Health Care REIT Stock Slides -15% With A 7-Day Losing Spree
Sabra Health Care REIT (SBRA) experienced a 7-day losing streak, with its stock sliding 15% and its market cap decreasing by about $789 million. Despite what Trefis describes as "strong operating performance and financial condition," the stock is considered "Risky" due to its high valuation. The article provides a detailed comparison of SBRA's returns against the S&P 500 and lists key financial metrics for the company.
Sabra Health Care (SBRA) director receives 817 stock units
Sabra Health Care REIT, Inc. director Lynne S. Katzmann received a grant of 817 stock units of common stock on May 29, 2026. These units were dividend equivalent payments on previously granted stock units and did not involve a cash exercise price. Following this transaction, Katzmann holds a total of 77,811 stock units, including both unvested and vested but deferred units.
Sabra Health Care REIT (SBRA) CFO receives 4,200 dividend-based stock units
Sabra Health Care REIT (SBRA) CFO Michael Lourenco was awarded 4,200 common stock units as dividend equivalents on previously granted units, at a price of $0.0000 per share. These units will vest and be paid according to the original awards' schedule. Following this acquisition, Lourenco directly holds 465,721 shares and stock units, including 282,615 units convertible to common shares, with additional indirect holdings in IRAs.
Sabra Health Care REIT (SBRA) director receives 817 stock units via dividend equivalents
Sabra Health Care REIT (SBRA) director Catherine Cusack received 817 stock units through dividend equivalent payments under the company's 2009 Performance Incentive Plan. Following this grant, Cusack directly holds 73,746 stock units, which include both unvested and vested-but-deferred units. This transaction was not an open-market trade but a grant reflecting dividend reinvestment on her existing stock units.
Sabra Health Care REIT (SBRA) director receives 817 stock units grant
Ann Kono, a director at Sabra Health Care REIT, Inc. (SBRA), received a grant of 817 common stock units on May 29, 2026. These units were issued as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan, with no purchase price. Following this transaction, Kono directly holds 59,876 stock units, including both unvested and vested but deferred units.
Sabra Health Care REIT (SBRA) CEO receives 14,003 stock units award
Richard K. Matros, CEO of Sabra Health Care REIT (SBRA), was awarded 14,003 stock units as compensation, identified as dividend equivalent payments on previously granted units under the company's 2009 Performance Incentive Plan. These units, granted at $0.00, increase his direct holdings to 942,401 shares, with an additional 1,857,686 shares held indirectly through a trust. The stock units will vest and be converted into common stock shares on the same schedule as his original units.
Sabra Health Care (SBRA) director gifts shares and receives stock units
Sabra Health Care REIT director Michael J. Foster reported gifting 500 shares of common stock and receiving 817 additional stock units as dividend equivalent payments. After these transactions, he directly owns 74,233 shares and indirectly holds 42,411.745 shares through a 401(k) plan. The report also notes unvested and vested but deferred stock units.
Sabra Healthcare REIT Is Maintained at Overweight by Wells Fargo
Wells Fargo has reiterated its "Overweight" rating for Sabra Healthcare REIT (NASDAQ:SBRA). The reconfirmation of the overweight rating implies Wells Fargo's continued positive outlook on Sabra Healthcare REIT's stock performance.
Lasalle Investment Management Securities LLC Purchases New Shares in Sabra Healthcare REIT, Inc. $SBRA
Lasalle Investment Management Securities LLC has acquired 3,534,217 new shares of Sabra Healthcare REIT (NASDAQ:SBRA) in the fourth quarter, a stake valued at approximately $66.9 million. This investment represents about 1.42% of the company and makes up 2.7% of Lasalle's investment portfolio. Other institutional investors have also adjusted their holdings, with 99.40% of SBRA stock owned by institutions and hedge funds.
Legal & General Group Plc Has $27.03 Million Stake in Sabra Healthcare REIT, Inc. $SBRA
Legal & General Group Plc significantly increased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 16.5% in the fourth quarter, bringing its total holding to 1,427,180 shares valued at approximately $27.03 million. Other institutional investors have also modified their positions in the company, with hedge funds and institutional investors owning 99.40% of the stock. Sabra Healthcare REIT reported Q1 earnings that met estimates and revenue that exceeded expectations, declaring a quarterly dividend of $0.30 per share, resulting in a 6.0% annualized yield.
SBRA - Sabra Healthcare REIT Inc Stock Price and Quote
This article provides a detailed financial overview of Sabra Healthcare REIT Inc (SBRA), including its stock price, key financial metrics, performance indicators, and recent news. It also lists analyst ratings and recent transactions by company insiders. The company's business involves acquiring, financing, and owning real estate properties.
Sabra (NASDAQ: SBRA) director reports 490-share gift and updates stock holdings
Sabra Health Care REIT director Michael J. Foster reported a bona fide gift of 490 shares of Common Stock on May 27, 2026. After this transaction, he directly holds 73,416 shares and indirectly holds 42,411.745 shares through a 401(k) Plan. The filing also notes he has 715 unvested and 53,484 vested but deferred stock units.
Sabra Health Care REIT, Inc., Issues Business Update and will Participate in Nareit’s REITweek 2026 Investor Conference
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) has released a business update on their website and announced their participation in Nareit’s REITweek 2026 Investor Conference from June 1-4, 2026. Key executives, including Rick Matros, Michael Costa, Darrin Smith, and Lukas Hartwich, will represent the company at the event. Sabra Health Care REIT operates as a self-administered real estate investment trust focused on the healthcare industry across the United States and Canada.
Sabra Health Care REIT to Present at Nareit’s REITweek 2026 Investor Conference
Sabra Health Care REIT, Inc. announced its participation in Nareit’s REITweek 2026 Investor Conference. The company will present at the conference to discuss its financial performance, portfolio, and future growth prospects with investors and industry analysts. This participation aims to enhance transparency and communicate Sabra's value proposition.
Sabra Health Care REIT (NASDAQ: SBRA) outlines $277M deals and $7.8B value
Sabra Health Care REIT (SBRA) detailed recent investment activities, including $277 million in managed senior housing and skilled nursing investments with a 7.9% initial cash yield, and a pipeline of nearly $410 million. The company reported a consolidated enterprise value of $7.8 billion as of March 31, 2026, supported by approximately $1.2 billion in liquidity. Sabra also highlighted its moderate leverage with Net Debt to Adjusted EBITDA at 5.04x and a strong balance sheet with no material debt maturities until 2028.
Top Sabra Health Care REIT executives head to New York investor summit
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) has released a business update and announced that its top executives, including Chair and CEO Rick Matros, CFO Michael Costa, CIO Darrin Smith, and EVP of Finance Lukas Hartwich, will be participating in Nareit’s REITweek 2026 Investor Conference from June 1-4, 2026. The company, a self-administered real estate investment trust, focuses on owning and investing in healthcare industry real estate across the United States and Canada. This participation highlights their engagement with the investment community regarding their business operations.
SBRA - US Senior Living Demand Will Unlock Future Value
Sabra Health Care REIT's (SBRA) fair value has slightly increased to $22.00, reflecting updated analyst expectations for revenue growth and profit margins. Bullish analysts foresee improved senior housing occupancy and growth potential, pushing some price targets higher, while bearish analysts view shares as closer to fair value due to slightly lower-than-expected 2026 FFO guidance. The REIT's outlook is supported by strong demand for senior living, strategic acquisitions, and limited new competition, though risks include operator transitions and regulatory changes.
Sabra (NASDAQ: SBRA) director makes 813-share stock gift, holds 73k
Sabra Health Care REIT, Inc. director Michael J. Foster gifted 813 shares of Common Stock on May 22, 2026, which were valued at $0.00 per share. Following this transaction, Foster directly holds 73,906 shares and indirectly holds 42,411.745 shares through a 401(k) Plan. His holdings also include 715 unvested stock units and 53,484 vested but deferred stock units.
S&P upgrades Sabra Health Care REIT stock outlook on asset mix
S&P Global Ratings has upgraded its outlook on Sabra Health Care REIT (NYSE:SBRA) to positive from stable, affirming its BB+ issuer credit rating. This upgrade is attributed to Sabra's expanded managed senior housing platform, which has grown to 90 consolidated properties, contributing to a 14.4% growth in same-property cash net operating income. S&P expects the company's vital debt to EBITDA ratio to improve to approximately 5.0x by year-end 2026, driven by significant investments and a shift towards private pay revenues in its portfolio.
Systematic Financial Management LP Has $41.91 Million Position in Sabra Healthcare REIT, Inc. $SBRA
Systematic Financial Management LP reduced its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 4.0% in the fourth quarter but still holds 2.21 million shares valued at $41.9 million. Sabra Healthcare REIT reported Q1 earnings of $0.16 per share, matching estimates, with revenue of $221.75 million, surpassing expectations and increasing 20.9% year-over-year. The company declared a quarterly dividend of $0.30 per share, offering a 5.8% yield, and analysts collectively rate the stock a "Moderate Buy" with an average target price of $22.30.
Sabra Health Care REIT stock (US78396U1051): dividend-focused healthcare landlord after latest earnings update
Sabra Health Care REIT remains focused on providing stable dividends from its US senior housing and skilled nursing portfolio, as highlighted by its recent first-quarter 2026 results. The company's business model relies on long-term leases generating stable rental income, with a requirement to distribute at least 90% of taxable income as dividends. With normalized FFO per share stable and affirmed full-year guidance, Sabra aims to attract income-focused investors despite ongoing industry pressures.
Sabra Reports Third Quarter 2024 Results; Updates 2024 Guidance
Sabra Health Care REIT Inc. (SBRA) has reported its third-quarter 2024 results and updated its guidance for the full year 2024. This information was made available through a press release and an SEC Form 8-K filing. Quantisnow, a real-time market data platform, alerted its Plus members about the publication and provides further details and related SEC filings for SBRA.
Sabra Healthcare REIT, Inc. $SBRA Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al
VIRGINIA RETIREMENT SYSTEMS ET Al significantly reduced its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 46.3% in the fourth quarter, selling 267,650 shares. Despite this, institutional investors and hedge funds still hold 99.40% of the stock, with other major holders like Vanguard and Principal Financial increasing their positions. Sabra Healthcare REIT reported quarterly EPS of $0.16, matching analyst estimates, and increased its quarterly dividend to $0.30 per share, offering a 5.7% annual yield.
Sabra Healthcare REIT stock hits 52-week high at 21.07 USD
Sabra Healthcare REIT Inc. (SBRA) has reached a new 52-week high, closing at $21.07, marking a 26% stock price increase over the past year. The company's $5.3 billion market cap and 5.72% dividend yield, along with strong Q1 2026 earnings exceeding revenue projections, are contributing factors. Analyst Cantor Fitzgerald raised its price target to $22.00, reflecting positive market sentiment and investor confidence in Sabra Healthcare's performance and growth prospects.
Sabra Healthcare REIT stock hits 52-week high at 21.07 USD
Sabra Healthcare REIT (SBRA) stock has reached a new 52-week high of $21.07, marking a 26% increase over the past year and a nearly 16% return in the last six months. The company reported strong Q1 2026 earnings, exceeding revenue projections, and analysts like Cantor Fitzgerald have raised price targets, reflecting positive market sentiment and investor confidence in its performance and growth prospects. SBRA also offers a 5.72% dividend yield and is considered slightly undervalued according to an InvestingPro analysis.
Sabra Healthcare REIT stock hits 52-week high at 21.07 USD
Sabra Healthcare REIT (SBRA) has reached a new 52-week high of $21.07, demonstrating a 26% stock price increase over the past year and a 16% return in the last six months. The company, with a $5.3 billion market cap, offers a 5.72% dividend yield and has maintained payments for 16 consecutive years. Despite its recent surge, InvestingPro analysis suggests the stock is still slightly undervalued.
Sabra Healthcare REIT Is Maintained at Neutral by Cantor Fitzgerald
Cantor Fitzgerald has maintained its Neutral rating on Sabra Healthcare REIT (SBRA). The report, issued 13 hours ago, reflects the firm's ongoing assessment of SBRA's financial position and market outlook.
Is Higher Q1 Revenue And An Affirmed Dividend Altering The Investment Case For Sabra (SBRA)?
Sabra Health Care REIT announced first-quarter 2026 results with US$221.75 million in revenue and affirmed a quarterly dividend of US$0.30 per share, despite a slight decrease in EPS. The article examines whether these results impact the investment thesis, noting the importance of sustained senior housing demand and a maintained dividend to its investment narrative. While the dividend affirmation is central, the high payout ratio and potential strain on the balance sheet for acquisitions remain key risks.
Cantor Fitzgerald raises Sabra Healthcare REIT price target to $22
Cantor Fitzgerald has increased its price target for Sabra Healthcare REIT Inc. (NASDAQ:SBRA) to $22.00 from $21.00, while maintaining a Neutral rating. The firm acknowledged Sabra Healthcare's extensive experience in senior housing operations and its solid financial health, highlighted by 16 consecutive years of dividend payments and a 5.78% yield. This comes as Sabra Healthcare recently exceeded revenue expectations in its Q1 2026 earnings report, further indicating strong financial performance.
UBS Group AG Raises Position in Sabra Healthcare REIT, Inc. $SBRA
UBS Group AG significantly increased its stake in Sabra Healthcare REIT, Inc. (SBRA) by 143.1% in the fourth quarter, bringing its total holdings to 1,460,219 shares valued at approximately $27.7 million. The REIT reported robust Q1 results, meeting EPS expectations and exceeding revenue estimates with a 20.9% year-over-year increase. Sabra Healthcare also declared a quarterly dividend of $0.30 per share, annualizing to a 5.8% yield, while analysts maintain a "Moderate Buy" rating with a $22 target price.
Sabra Healthcare REIT (NASDAQ:SBRA) Rating Lowered to "Sell" at Wall Street Zen
Wall Street Zen has downgraded Sabra Healthcare REIT (NASDAQ:SBRA) from "hold" to "sell," despite a "Moderate Buy" consensus from other analysts and a $22.00 price target. The company reported quarterly EPS of $0.16, meeting expectations, and revenue of $221.75 million, which was above estimates and up 20.9% year-over-year. Institutional investors have made minor adjustments to their holdings in SBRA, which currently has 99.40% ownership by institutional investors and hedge funds.
Sabra Healthcare REIT (SBRA) Stock Price, News & Analysis
This article provides a comprehensive overview of Sabra Healthcare REIT (SBRA), including its current stock price, recent news, and detailed financial analysis. It covers key statistics, company operations, analyst ratings, earnings forecasts, dividend information, and institutional ownership, indicating a "Moderate Buy" consensus rating despite concerns about dividend sustainability.
Mitsubishi UFJ Trust & Banking Corp Sells 111,862 Shares of Sabra Healthcare REIT, Inc. $SBRA
Mitsubishi UFJ Trust & Banking Corp significantly reduced its stake in Sabra Healthcare REIT (NASDAQ: SBRA) by 75.2% in Q4, selling over 111,000 shares but still holding 36,884 shares worth $699,000. Despite this, Sabra Healthcare REIT has a "Moderate Buy" consensus rating from analysts with a $22.00 price target and recently declared a quarterly dividend of $0.30 per share. The company reported Q1 EPS of $0.16, meeting estimates, and revenue of $221.75 million, exceeding expectations, while providing FY 2026 EPS guidance of $1.550-$1.590.
Principal Financial Group Inc. Acquires 4,431,897 Shares of Sabra Healthcare REIT, Inc. $SBRA
Principal Financial Group Inc. increased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 21.6%, acquiring over 4.4 million additional shares, bringing its total ownership to 10.01% valued at approximately $472.6 million. Sabra Healthcare REIT reported Q4 EPS of $0.16, meeting estimates, and revenue of $221.75 million, surpassing expectations with a 20.9% year-over-year increase. The company also declared a quarterly dividend of $0.30, representing a 5.9% yield, although its payout ratio is high at 190.48%.
Vanguard Group Inc. Buys 481,231 Shares of Sabra Healthcare REIT, Inc. $SBRA
Vanguard Group Inc. increased its stake in Sabra Healthcare REIT (NASDAQ: SBRA) by 1.4%, purchasing an additional 481,231 shares and bringing its total holding to over 35.4 million shares valued at approximately $671 million. Sabra Healthcare REIT recently beat Q1 revenue and FFO estimates, raised its FY 2026 EPS guidance, and declared a quarterly dividend of $0.30 per share. The company's management, however, noted potential near-term uncertainty regarding capital allocation and payout sustainability due to tight skilled-nursing deal flow and strong competition.
Strs Ohio Has $16.50 Million Stock Position in Sabra Healthcare REIT, Inc. $SBRA
Strs Ohio significantly increased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 1,916.2% in Q4, holding 871,000 shares valued at approximately $16.5 million. The company recently reported Q1 results that beat revenue and FFO estimates, raising its FY-2026 EPS guidance and declaring a $0.30 quarterly dividend. Despite a "Moderate Buy" consensus from analysts with a $22 target, concerns remain regarding the high dividend payout ratio (~190%) and potential uncertainties from future guidance review following recent investments.
